[go: up one dir, main page]

MX2019011510A - Metodos y composiciones para mejorar la salud. - Google Patents

Metodos y composiciones para mejorar la salud.

Info

Publication number
MX2019011510A
MX2019011510A MX2019011510A MX2019011510A MX2019011510A MX 2019011510 A MX2019011510 A MX 2019011510A MX 2019011510 A MX2019011510 A MX 2019011510A MX 2019011510 A MX2019011510 A MX 2019011510A MX 2019011510 A MX2019011510 A MX 2019011510A
Authority
MX
Mexico
Prior art keywords
compositions
methods
enhancing health
enhancing
health
Prior art date
Application number
MX2019011510A
Other languages
English (en)
Inventor
Kleidon William
Original Assignee
Ojai Energetics Pbc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ojai Energetics Pbc filed Critical Ojai Energetics Pbc
Publication of MX2019011510A publication Critical patent/MX2019011510A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/105—Persulfides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Las composiciones, métodos y equipos descritos en la presente pueden formularse como un suplemento nutricional o un suplemento dietético. La composición descrita en la presente puede proporcionar nutrientes o compuestos que de otro modo no se consumirían en cantidades suficientes en una dieta normal, y pueden contribuir al bienestar físico y al bienestar emocional de un sujeto.
MX2019011510A 2017-03-30 2018-03-23 Metodos y composiciones para mejorar la salud. MX2019011510A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762479091P 2017-03-30 2017-03-30
US201762506475P 2017-05-15 2017-05-15
US201862632965P 2018-02-20 2018-02-20
PCT/US2018/024061 WO2018183115A1 (en) 2017-03-30 2018-03-23 Methods and compositions for enhancing health

Publications (1)

Publication Number Publication Date
MX2019011510A true MX2019011510A (es) 2020-01-09

Family

ID=63676925

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019011510A MX2019011510A (es) 2017-03-30 2018-03-23 Metodos y composiciones para mejorar la salud.
MX2022004262A MX2022004262A (es) 2017-03-30 2019-09-26 Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022004262A MX2022004262A (es) 2017-03-30 2019-09-26 Composiciones de cannabinoides para usarse en mejorar la salud, metodos de fabricacion y uso de las mismas.

Country Status (11)

Country Link
US (1) US20200101041A1 (es)
EP (1) EP3600271A4 (es)
JP (3) JP2020512358A (es)
CN (1) CN110709069A (es)
AU (2) AU2018243694A1 (es)
BR (1) BR112019020554A2 (es)
CA (1) CA3057994A1 (es)
GB (1) GB2577810A (es)
IL (1) IL269642B1 (es)
MX (2) MX2019011510A (es)
WO (1) WO2018183115A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US11202771B2 (en) 2018-01-31 2021-12-21 Treehouse Biotech, Inc. Hemp powder
EP3771313B1 (en) * 2018-04-04 2023-10-04 Vinsan Therapeutics Inc. Topical cannabinoid formulations and instillates, kits, and methods for treating integumentary wounds, and uses thereof
WO2019220324A2 (en) * 2018-05-14 2019-11-21 Buzzelet Development And Technologies Ltd Terpene-enriched cannabinoid compositions and uses thereof in the treatment of infectious conditions
EP3864000A4 (en) 2018-10-10 2022-08-10 Treehouse Biosciences, Inc. CANNABIGEROL SYNTHESIS
WO2020084450A1 (en) * 2018-10-23 2020-04-30 Radient Technologies Innovations Inc. Method of automating cannabis decarboxylation and extraction by recursive decarboxylation, sampling, and extraction steps
WO2020084425A1 (en) * 2018-10-24 2020-04-30 Radient Technologies Innovations Inc. Side effect and symptom relief
US10609944B1 (en) 2018-12-14 2020-04-07 Natural Extraction Systems, LLC Compositions comprising 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-3-hydroxy-5-pentylphenolate and 2-[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
US10959961B2 (en) * 2018-12-14 2021-03-30 Natural Extraction Systems, LLC Methods of administering anionic cannabinoid molecules dissolved in water
EP3893673A4 (en) 2018-12-14 2023-05-03 Natural Extraction Systems, LLC COMPOSITIONS AND METHODS RELATED TO ANIONIC CANNABINOID MOLECULES
CN113993523A (zh) 2019-04-17 2022-01-28 指南针探路者有限公司 用赛洛西宾治疗抑郁症和其他各种病症
US11622956B1 (en) 2019-06-26 2023-04-11 RCR BioPharma Compound and method for treating diseases and disorders
WO2021016710A1 (en) * 2019-07-30 2021-02-04 Tassili Life Sciences, Corp. Controlled release formulations of multiple active pharmaceutical agents, and psilocybe-derived agents in combination with cannabis-derived agents and methods for their use
US10780075B1 (en) * 2019-07-31 2020-09-22 Etain IP, LLC Water soluble cannabis composition
CN115243568B (zh) 2019-09-12 2023-10-17 努利希尔有限公司 受控释放的核-壳粒子及包含其的悬浮液
WO2022026960A1 (en) 2020-07-31 2022-02-03 Natural Extraction Systems, LLC Compositions and methods related to excipients and cannabinoid formulations
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol
US20220362319A1 (en) * 2021-05-12 2022-11-17 PPM Labs LLC Cannabinoid Concentration Process
CA3229017A1 (en) 2021-08-19 2023-02-23 Mind Medicine, Inc. Lyophilized orally disintegrating tablet formulations of d-lysergic acid diethylamide for therapeutic applications
EP4486448A1 (en) 2022-03-04 2025-01-08 Reset Pharmaceuticals, Inc. Co-crystals or salts comprising psilocin
CN120213091B (zh) * 2025-05-28 2025-08-15 浙江机电职业技术大学 一种高温共烧结的多层异形陶瓷高温传感器及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2400320B (en) 2001-05-04 2005-06-08 Gw Pharma Ltd Cannabinoid-rich extracts
US8980940B2 (en) * 2006-11-10 2015-03-17 Johnson Matthey Public Limited Company Stable cannabinoid compositions and methods for making and storing them
US8642645B2 (en) * 2011-05-20 2014-02-04 Brooks Kelly Research, LLC. Pharmaceutical composition comprising Cannabinoids
EP4137142A1 (en) * 2013-03-14 2023-02-22 Purple Mundo, Inc. Bioactive concentrates and uses thereof
US20160279073A1 (en) * 2013-10-31 2016-09-29 Full Spectrum Laboratories, Ltd. Terpene and cannabinoid formulations
JP2017535539A (ja) * 2014-10-21 2017-11-30 ユナイテッド カナビス コーポレイション 大麻抽出物ならびにその調製方法および使用方法
US9375417B2 (en) * 2014-12-04 2016-06-28 Mary's Medicinals LLC Transdermal cannabinoid formulations
MX386351B (es) * 2015-01-31 2025-03-18 Constance Therapeutics Inc Métodos para la preparación de extractos y composiciones de aceite de cannabis.
CA2977802A1 (en) * 2015-02-27 2016-09-01 Ebbu, LLC Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
US9747740B2 (en) * 2015-03-02 2017-08-29 Ford Global Technologies, Llc Simultaneous button press secure keypad code entry
CA2995418A1 (en) * 2015-08-11 2017-02-16 KannaInnovations LLC Topical compositions comprising hydroxy acids and cannabinoids for skin care
US10517911B2 (en) 2016-05-06 2019-12-31 Harvest Direct Enterprises Llc Manufacturing methods, compositions, and medical applications of orally administered cannabis pharmaceuticals using representative/total/complete cannabis extractions (cannabis infused pills)
MX386620B (es) * 2016-08-03 2025-03-19 Zelda Therapeutics Operations Pty Ltd Composicion de cannabis
US20180344786A1 (en) * 2017-06-06 2018-12-06 NC3 Systems System and method enhanced cannabiniod effect delivery
MX2020002401A (es) * 2017-09-28 2020-07-22 Canopy Growth Corp Composiciones de cannabinoides comestibles.

Also Published As

Publication number Publication date
GB201914076D0 (en) 2019-11-13
US20200101041A1 (en) 2020-04-02
IL269642A (en) 2019-11-28
BR112019020554A2 (pt) 2020-04-28
IL269642B1 (en) 2025-12-01
CN110709069A (zh) 2020-01-17
JP7624035B2 (ja) 2025-01-29
MX2022004262A (es) 2022-05-06
AU2018243694A1 (en) 2019-10-17
JP2023139315A (ja) 2023-10-03
GB2577810A (en) 2020-04-08
EP3600271A4 (en) 2020-12-16
JP2020512358A (ja) 2020-04-23
AU2024203369A1 (en) 2024-06-06
EP3600271A1 (en) 2020-02-05
WO2018183115A1 (en) 2018-10-04
CA3057994A1 (en) 2018-10-04
JP2025061440A (ja) 2025-04-10

Similar Documents

Publication Publication Date Title
MX2019011510A (es) Metodos y composiciones para mejorar la salud.
MX2017007550A (es) Composiciones microencapsuladas de cannabinoides.
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
ECSP15034601A (es) Composiciones nutricionales que contienen treonato de magnesio, y sus usos
MX2017008813A (es) Polvo de coleopteros.
BR112018003780A2 (pt) composições que compreendem um composto de urolitina
ECSP17043318A (es) Composición que contiene quitina y proteínas digeribles
MX2016012559A (es) Composiciones de protector solar.
MX2013005406A (es) Composicion nutricional adaptada a la edad con grasas animales y grasas vegetales.
MX2015015630A (es) Acido graso del aceite de bogol.
BR112015026207A2 (pt) uso de uma preparação na fabricação de uma composição nutricional, composição nutricional, uso de uma composição nutricional, uso de uma composição, composição, e método para tratamento ou fornecimento de gerenciamento nutricional de pacientes com hiperfenilalaninemia e/ou pacientes com fenilcetonúria
MX2021014352A (es) Composiciones de fibra soluble de superoxido dismutasa.
MX384995B (es) Composición que contiene aceite vegetal, caramelo y compuestos fenólicos.
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
BR112015020568A2 (pt) composição para melhorar o desenvolvimento cognitivo, cerebral e/ou do snc do recém-nascido e método para o uso da mesma
PH12019550209A1 (en) A nutritional composition for use to enhance attention and/or reduce impulsivity
PH12017500203A1 (en) Nutritional composition for use in promoting gut and/or liver maturation and/or repair
PH12015502693A1 (en) A composition, process and a kit for sugar processing
BR112022007676A2 (pt) Composições e métodos para aumentar glutationa para uso na saúde cerebral
CL2020000528A1 (es) Composiciones y uso para promover, apoyar u optimizar la mielinización de novo. (divisional solicitud 201801600)
MX381153B (es) Composiciones nutricionales sintéticas específicas de género y sistemas nutricionales que las comprenden.
GB2528406A (en) Prebiotic composition and method of its use
PH12021551924A1 (en) A nutritional composition for use to enhance executive function
EA201992271A1 (ru) Способы и композиции для улучшения здоровья
PH22017001036U1 (en) Food supplement for the nervous system